Cybin (FRA:R7E1) EV-to-Revenue : (As of Jun. 24, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cybin EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cybin's enterprise value is €155.12 Mil. Cybin's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil. Therefore, Cybin's EV-to-Revenue for today is .

The historical rank and industry rank for Cybin's EV-to-Revenue or its related term are showing as below:

During the past 4 years, the highest EV-to-Revenue of Cybin was 625.69. The lowest was -19.43. And the median was 48.00.

FRA:R7E1's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.69
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Cybin's stock price is €0.2578. Cybin's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Therefore, Cybin's PS Ratio for today is .

Cybin EV-to-Revenue Historical Data

The historical data trend for Cybin's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin EV-to-Revenue Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

171.92

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Cybin's EV-to-Revenue

For the Biotechnology subindustry, Cybin's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cybin's EV-to-Revenue falls into.

Cybin EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cybin's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	155.119	/	0
	=

Cybin's current Enterprise Value is €155.12 Mil.
Cybin's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Cybin (FRA:R7E1) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cybin's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.2578	/	0
	=

Cybin's share price for today is €0.2578.
Cybin's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

Cybin EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cybin's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CYBN:USA CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines